INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 3.500
0.00 (0.00%)
At close: Jan 7, 2026
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 315.61 million as of January 13, 2026. Its market cap has decreased by -16.33% in one year.
Market Cap
315.61M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.50
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has decreased from 452.37M to 315.61M, a decrease of -30.23%. That is a compound annual growth rate of -9.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 329.82M | -13.64% |
| Dec 30, 2025 | 381.89M | 1.25% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.55B |
| Nordhealth AS | 2.77B |
| Photocure ASA | 2.06B |
| Thor Medical ASA | 1.81B |
| ArcticZymes Technologies ASA | 1.22B |
| Omda AS | 963.86M |
| Vistin Pharma ASA | 922.37M |
| Gentian Diagnostics ASA | 909.92M |